Skip to main content

IPHA · Innate Pharma SA · Proposed Sales

Track IPHA — free
$1.38 -0.11 (-7.38%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$154.15M
Shares
111.70M
Volume · Nov 13 17.29K Avg daily vol (3M) 38.9K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 7 filings 7 filers Visit website Investor relations